...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >DRUG UTILIZATION EVALUATION OF ANTIDIABETIC DRUGS AMONG TYPE 2 DIABETES PATIENTS OF TAMIL NADU
【24h】

DRUG UTILIZATION EVALUATION OF ANTIDIABETIC DRUGS AMONG TYPE 2 DIABETES PATIENTS OF TAMIL NADU

机译:泰米尔纳德邦2型糖尿病患者中抗菌药物的利用评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives: The aim of the study was to assess the prescribing pattern of antidiabetic drugs in Type 2 diabetes outpatients visiting to Diabetes Centre, Chennai. Methods: A prospective study was carried out by evaluating 115 prescriptions of antidiabetic drugs over the period of 4 months to assess the prescribing pattern of antidiabetic drugs and also drugs used for other complications of Type 2 DM. Results: Totally, 115 patients were evaluated, 58 were of male and 57 were of female. An average number of drugs per encounter were found to be 4.47. An average number of antidiabetic drugs were found to be 2.56. In this study, the most commonly prescribed oral hypoglycemic drug class as single-drug regimen was that of alpha-glucosidase inhibitors (16.326%), dipeptidyl peptidase-4 (DPP-4) inhibitors (14.62%), biquanides (12.9%), thiazolidine diones (9.8%), sulfonyl urea (7.82%) and meglitinides (2.38%), and in multi drug regimen metformin + alpha-glucosidase inhibitors (11.56%) were commonly prescribed. Conclusion: Most commonly used drug was alpha-glucosidase inhibitors, followed by DPP-4 inhibitors and biguanides. All the patients received combination therapy to achieve the glycemic control.
机译:目的:该研究的目的是评估前往钦奈糖尿病中心的2型糖尿病门诊患者的抗糖尿病药物处方模式。方法:前瞻性研究通过评估4个月期间的115种抗糖尿病药处方来评估抗糖尿病药以及用于2型DM其他并发症的药物的处方模式。结果:共评估115例患者,其中男性58例,女性57例。每次遭遇的平均毒品数量为4.47。发现抗糖尿病药物的平均数为2.56。在这项研究中,最常用的口服降糖药类别为单药方案,包括α-葡萄糖苷酶抑制剂(16.326%),二肽基肽酶-4(DPP-4)抑制剂(14.62%),双胍类(12.9%),通常处方使用噻唑烷二酮(9.8%),磺酰脲(7.82%)和美格替尼(2.38%),在多药方案中,二甲双胍+α-葡萄糖苷酶抑制剂(11.56%)被处方。结论:最常用的药物是α-葡萄糖苷酶抑制剂,其次是DPP-4抑制剂和双胍。所有患者均接受联合治疗以实现血糖控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号